Trial: KF6019-02
Tegacorat (GRM-01)
Title | Description |
|---|---|
| Trial ID | KF6019-02 |
| Compound | Tegacorat (GRM-01) |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 2 |
| Brief title | A Phase 2 Trial to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tegacorat in Male Participants 4 to <7 Years of Age With Duchenne Muscular Dystrophy |
| Indication | Duchenne Muscular Dystrophy |
| UTN | U1111-1339-2419 |
| CTG ID | NCT07911995 |
| CTIS ID (former EudraCT) | 2026-526326-40-00 |
| Trial status | Active, not recruiting |
| FPI | |
| LPO | |
| Countries | Czech Republic; Georgia; Hungary; Poland; Romania; Slovakia; Turkey, United States |
| Gender | Male |
| Age | 4-6 years |
| Results | No |
| Pubmed | |
| Documents |